Treating Patients Who Are Eligible for COVID-19 Therapies

May 20, 2022

The Illinois Department of Public Health (IDPH) encourages healthcare professionals to quickly assess patients who have COVID-19 (within five days of the onset of symptoms) to determine whether they are eligible for treatment. At this time, four options are available for treating mild to moderate COVID-19 illness in non-hospitalized people:

  1. Paxlovid
  2. Bebtelovimab
  3. Remdesivir
  4. Molnupiravir

Remdesivir is currently the only outpatient treatment option for children under the age of 12 years.

These treatments can lower the chance of progression to severe illness, hospitalization and death and can be administered at home or in an outpatient setting. Prescriptions can be sent to IDPH’s federal pharmacy partners (Walgreens, Walmart, CVS and Meijer) or community pharmacies listed in this treatment locator.

Learn more with IDPH’s COVID-19 Treatment Options document. If you have questions, please contact the Department by email or call 800-889-3931.

You may also contact the ISMS Health Policy Research and Advocacy team by email.

Share this article:

Cookie Consent

Cookies are required for some functionality on our site. View our privacy policy for more information.